Clarus Ventures is a private equity general partner firm headquartered in Cambridge, MA, United States and has other offices in United States.
OrbiMed Israel, Clarus, and HealthCap, with participation from Pontifax, led a $32m Series A funding for Tisbury Pharmaceuticals.
Clarus and the Global Health Investment Fund have invested $25m in leader in global health innovation company PATH.
Biopharmaceutical company Cleave Biosciences completed a $37m Series B financing round from Arcus Ventures, NEA, 5AM Ventures and others.
Read more news concerning Clarus Ventures
A sampling of Clarus Ventures portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?